References
- Pathak M A, Dall'acqua F, Rodighiero G, et al. Metabolism of psoralens. J Invest Dermatol 1974; 62: 347
- Bonnot D, Beani J C, Boitard M, et al. Importance de la determination de la cinétique plasmatique du méthoxy-8-psoralène dans le traitement du psoriasis par PUVA thérapie. J Pharm Clin 1987; 6: 309–26
- Brickl R, Schmid J, Koss F W. Pharmacokinetics and pharmacodynamics of psoralens after oral administration: considerations and conclusions. Natl Cancer Inst Monogr 1984; 66: 63–7
- Herfst M J, de Wolff F A. Intraindividual and interindividual variability in 8-methoxypsoralen kinetics and effect in psoriatic patients. Clin Pharmacol Ther 1983; 34: 117–24
- Jansen C T, Wilen G, Ylitalo P, et al. Inter-and intraindividual variations in serum methoxsalen levels during repeated oral exposure. Curr Ther Res 1983; 33: 258–64
- Lauharanta J, Juvakoski T. Pharmacokinetics of 8-methoxypsoralen in serum and suction blister fluid. Arch Dermatol Res 1982; 273: 111–14
- Schafer-Korting M, Korting H. Intra-individual variations of 8-methoxypsoralen plasma levels. Arch Dermatol Res 1982; 272: 1–7
- Sullivan T J, Walter J L, Kouba R F, et al. Bioavailability of a new oral methoxsalen formulation. A serum concentration and photosensitivity response study. Arch Dermatol 1986; 122: 768–71
- Swanbeck G, Ehrsson H, Ehrnebo M, et al. Serum concentration and phototoxic effect of methoxypsoralen in patients with psoriasis. Clin Pharmacol Ther 1979; 25: 478–80
- Sakuntabhai A, Farr P M, Diffey B L. Variable photosensitivity and clinical response of psoriasis to PUVA with conventional 8-methoxypsoralen dosage. Br J Dermatol 1992; 127: 421
- Ljunggren B, Carter M D, Albert J, et al. Plasma levels of 8-methoxypsoralen determined by high-pressure liquid chromatography in psoriatic patients ingesting drug from two manufacturers. J Invest Dermatol 1980; 74: 59–62
- Beani J C, Didier B, Bonnot D, et al. Apport des dosages sanguins du 8-méthoxypsoralène a la PUVA thérapie. Ann Dermatol Venereal 1985; 112: 101–2
- Roelandts R, van Boven M, de Heyn T, et al. Dietary influences on 8 MOP plasma levels in PUVA patients with psoriasis. Br J Dermatol 1981; 105: 569–72
- Ehrsson H, Nisson S, Ehrnebo M, et al. Effect of food on kinetics of 8 methoxsalen. Clin Pharmacol Ther 1979; 25: 167–71
- Bech-Thomsen N, Angelo H R, Knudsen E A. The influence of food on 8-methoxypsoralen serum concentration and minimal phototoxic dose. Br J Dermatol 1992; 127: 620–4
- Herfst M J, de Wolff F A. Influence of food on the kinetics of 8-methoxypsoralen in serum and suction blister fluid in psoriatic patients. Eur J Clin Pharmacol 1982; 23: 75–80
- Goldstein D P, Carter M D. Minimal phototoxic doses and 8 MOP plasma levels in PUVA patients. J Invest Dermatol 1982; 78: 429–33